Radin Q Tablets 150 mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.
MFDS item code 201901235 · Approved 2019.02.26
This product's status changed to Expired on 2024.02.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastric acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
This medication is helpful in treating ulcers of the stomach and duodenum, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in preventing Mendelson syndrome before surgery and treating ulcers after surgery, as well as ulcers due to the use of non-steroidal anti-inflammatory drugs. It improves inflammation or bleeding of the gastric mucosa during acute and chronic gastritis exacerbations and is also used for upper gastrointestinal bleeding and acute stress ulcers. Additionally, it helps relieve symptoms of hyperacidity, heartburn, and acid regurgitation. In summary, this medication is used effectively to treat various ulcers, inflammation, and related symptoms of the stomach and duodenum.
Administer 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for concomitant use to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, and in conditions caused by nonsteroidal anti-inflammatory drugs usually within 8 weeks, although the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment at 150 mg 3 times daily and increase the dose if needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration at 150 mg twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) associated with acute gastritis or acute exacerbation of chronic gastritis Administer 150 mg once daily at bedtime. 3. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient’s condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
For patients aged 12 years or older, administer 75 mg orally twice daily (for oral solution only). For those aged 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.
This drug should not be used in patients who have a history of allergy or hypersensitivity reactions to any of its components. Administration should also be avoided in patients with a history of acute porphyria. In patients with poor kidney function, dosage adjustment or interval modification is necessary as this drug may not be adequately excreted, leading to increased blood concentration. Caution is also required in patients with impaired liver function. Caution should be exercised when administering to patients who have previously experienced drug hypersensitivity or to elderly patients. Patients taking non-steroidal anti-inflammatory drugs need to be particularly cautious, and their condition should be regularly monitored. Since this drug can mask symptoms of gastric cancer, patients with gastric ulcers or those over middle age who have newly developed dyspeptic symptoms should confirm the presence of malignant diseases before using this medication. Patients with Helicobacter pylori-positive gastric and duodenal ulcers should undergo eradication therapy. This drug can rarely cause serious allergic reactions or shock, so if any adverse reactions occur during administration, treatment should be stopped immediately and medical attention sought. Various side effects such as blood abnormalities, liver function abnormalities, cardiac rhythm problems, gastrointestinal symptoms, and neurological symptoms can occur, so if any unusual symptoms appear, immediate consultation with medical professionals is required. Regular blood tests, liver function tests, and kidney function tests should be conducted for long-term use or high-dose administration. Elderly, chronically ill patients, and immunocompromised individuals may be at increased risk for pneumonia, warranting caution. Patients should avoid driving or operating dangerous machinery if experiencing dizziness or drowsiness. Drug interactions may occur; therefore, patients should inform healthcare providers of any other medications they are taking. Women who are pregnant or may become pregnant and those who are breastfeeding should carefully consider the risks and benefits if this medication is necessary. Safety in children has not been sufficiently confirmed, hence caution is necessary in its use. Although specific overdose symptoms are rare, appropriate treatment such as vomiting or gastric lavage may be required. It is safe to keep this medication out of the reach of children and not to transfer it to other containers. This drug reduces gastric acid secretion, which may promote bacterial growth in the gastrointestinal tract, requiring caution including ophthalmic examinations for long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is recommended to store the medication at room temperature, between 1°C and 30°C, to maintain its effectiveness and prevent deterioration.
Pale yellow to yellow circular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.